SCHEMBL6235089

SCHEMBL6235089

COc1cc(OCc2c(F)cccc2Cl)ccc1C=O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.48
MAPT P10636 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
AR P10275 1/20 0.46
GPBAR1 Q8TDU6 1/20 0.45
TP53 P04637 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAOB P27338 2/20 0.43
ALOX12 P18054 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GAA P10253 1/20 0.43
TUBB1 Q9H4B7 1/20 0.43
KDM4E B2RXH2 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6702861 0.91 ALDH1A1 (0.49) ALDH1A1MAPTTDP1SMN1; SMN2GPBAR1
SCHEMBL6232024 0.86 AR (0.50) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL6238955 0.85 SMN1; SMN2 (0.47) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL18601076 0.83 KMT2A (0.50) ALDH1A1LMNATDP1SMN1; SMN2AR
SCHEMBL6232985 0.80 PARP10 (0.62) ALDH1A1MAPTKMT2AMEN1MAOB
SCHEMBL18600769 0.80 HTT (0.46) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL18600867 0.79 AR (0.44) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL2362378 0.77 MAOA (0.58) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL6685562 0.77 ALDH1A1 (0.57) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
SCHEMBL3219291 0.77 ALDH1A1 (0.54) ALDH1A1LMNAMAPTTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005000309-A2 CHEMICAL COMPOUNDS IONIX PHARMACEUTICALS LIMITED (GB) 2005-01-06 WO disclosed
WO-2004087125-A1 AMINO ACID DERIVATIVES AS INHIBITORS OF MAMMALIAN SODIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2004-10-14 WO disclosed